Значения термина localise prostate на английском

Radiotherapy is a well-accepted treatment modality for patients with localised prostate cancer.

Background: Optimal management strategies for clinically localised prostate cancer are debated.

Background: Little information is available on the long-term outcomes of patients with localised prostate cancer.

Background: There is limited evidence relating to the cost-effectiveness of treatments for localised prostate cancer.

Therefore, our patients' preferences are of major importance and this can be illustrated by decision-making in localised prostate cancer.

These findings may inform future policy discussions about strategies to improve efficiency of treatment selection for localised prostate cancer.

Prospective studies are needed to confirm the independent prognostic potential of p53 overexpression in patients with localised prostate cancer.

Conclusions: Patients with stage I+II localised prostate gland carcinoma have improved survival compared with the normal male population.

Conclusions: Longer follow-up and modelling are required to determine the most cost-effective treatment for localised prostate cancer over a man's lifetime.

The study says those diagnosed with localised prostate cancer have a good prognosis, with many surviving more than 10 years without treatment.

Objective: To determine the frequency of lymph node involvement in patients with clinically localised prostate adenocarcinoma who had radical prostatectomy and extended pelvic lymphadenectomy.

We have previously demonstrated significantly elevated levels of plasma TF antigen as well as systemic coagulation and platelet activation in patients with localised prostate cancer.